World's Best Scientists 2026 revealed!

D-Index & Metrics

Immunology

D-Index
61
Citations
10522
World Ranking
3275
National Ranking
223

Michael Mahler publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Michael Mahler sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 279 publications — 59th percentile

59% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Michael Mahler D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Michael Mahler sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 61 D-Index — 36th percentile

36% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Michael Mahler is affiliated with Heidelberg University in Germany and conducts research primarily in the field of Medicine. Their work spans various subfields including Rheumatology, Immunology, Epidemiology, Radiology, Nuclear Medicine and Imaging, as well as Genetics.

The scientist frequently publishes on topics related to Systemic Lupus Erythematosus Research, Rheumatoid Arthritis Research and Therapies, Monoclonal and Polyclonal Antibodies Research, Inflammatory Myopathies and Dermatomyositis, Systemic Sclerosis and Related Diseases, Diabetes and associated disorders, and S100 Proteins and Annexins.

Michael Mahler has contributed articles to several well-recognized scientific venues. Among the most frequent publication venues are:

  • Diagnostics
  • Lara D. Veeken
  • Autoimmunity Reviews
  • Frontiers in Immunology
  • Arthritis & Rheumatology

Their recent papers showcase a focus on autoimmune and inflammatory diseases, with selected titles including:

  • "Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome", 2020, Frontiers in Immunology
  • "Serum calprotectin: a promising biomarker in rheumatoid arthritis and axial spondyloarthritis", 2020, Arthritis Research & Therapy
  • "A review and meta-analysis of anti-ribosomal P autoantibodies in systemic lupus erythematosus", 2020, Autoimmunity Reviews
  • "Circulating Calprotectin as a Biomarker of COVID-19 Severity", 2021, Expert Review of Clinical Immunology
  • "Precision medicine in the care of rheumatoid arthritis: Focus on prediction and prevention of future clinically-apparent disease", 2020, Autoimmunity Reviews

Collaboration is a significant part of Michael Mahler's research activity. Frequent coauthors include Chelsea Bentow, Marvin J. Fritzler, Mary Ann Aure, Laura Martínez-Prat, and Gary L. Norman. These collaborations reflect ongoing engagement with researchers experienced in clinical immunology and rheumatology.

Best Publications

  • Idiopathic inflammatory myopathies and the anti-synthetase syndrome: a comprehensive review.

    Michael Mahler;Frederick W. Miller;Marvin J. Fritzler

  • Latest update on the Ro/SS-A autoantibody system.

    J. Schulte-Pelkum;M. Fritzler;M. Mahler

  • Clinical Features and Treatment Outcomes of Necrotizing Autoimmune Myopathy

    Charles D. Kassardjian;Vanda A. Lennon;Nora B. Alfugham;Michael Mahler

  • Current concepts and future directions for the assessment of autoantibodies to cellular antigens referred to as anti-nuclear antibodies

    Michael Mahler;Pier Luigi Meroni;Xavier Bossuyt;Marvin J. Fritzler

  • Anti-DFS70/LEDGF Antibodies Are More Prevalent in Healthy Individuals Compared to Patients with Systemic Autoimmune Rheumatic Diseases

    Michael Mahler;Todd Parker;Carol L. Peebles;Luis E. Andrade

  • Carbamylation and antibodies against carbamylated proteins in autoimmunity and other pathologies

    Jing Shi;Peter A. van Veelen;Michael Mahler;George M.C. Janssen

  • Closing the serological gap: promising novel biomarkers for the early diagnosis of rheumatoid arthritis.

    Leendert A. Trouw;Michael Mahler

  • Anti-Phospholipid Antibodies in COVID-19 Are Different From Those Detectable in the Anti-Phospholipid Syndrome.

    Maria Orietta Borghi;Asmaa Beltagy;Emirena Garrafa;Daniele Curreli

  • In vivo pathogenicity of IgG from patients with anti-SRP or anti-HMGCR autoantibodies in immune-mediated necrotising myopathy.

    Cécile Bergua;Hélène Chiavelli;Yves Allenbach;Louiza Arouche-Delaperche

  • Clinical significance of antibodies to Ro52/TRIM21 in systemic sclerosis

    Marie Hudson;Janet Pope;Michael Mahler;Solène Tatibouet

  • Novel aspects of autoantibodies to the PM/Scl complex: Clinical, genetic and diagnostic insights

    Michael Mahler;Reinout Raijmakers

  • Epitope specificity and significance in systemic autoimmune diseases.

    Michael Mahler;Marvin J. Fritzler

  • Anti-HMGCR antibodies as a biomarker for immune-mediated necrotizing myopathies: A history of statins and experience from a large international multi-center study

    Lucile Musset;Yves Allenbach;Olivier Benveniste;Olivier Boyer

  • Importance of the dense fine speckled pattern on HEp-2 cells and anti-DFS70 antibodies for the diagnosis of systemic autoimmune diseases

    Michael Mahler;John G. Hanly;Marvin J. Fritzler

  • Anti–Citrullinated Protein Antibodies Are Associated With Neutrophil Extracellular Traps in the Sputum in Relatives of Rheumatoid Arthritis Patients

    M. Kristen Demoruelle;Kylie K. Harrall;Linh Ho;Monica M. Purmalek

  • Clinical characterization of antiphospholipid syndrome by detection of IgG antibodies against β2 -glycoprotein i domain 1 and domain 4/5: ratio of anti-domain 1 to anti-domain 4/5 as a useful new biomarker for antiphospholipid syndrome.

    Laura Andreoli;Cecilia B. Chighizola;Cecilia Nalli;Maria Gerosa

  • The clinical significance of the dense fine speckled immunofluorescence pattern on HEp-2 cells for the diagnosis of systemic autoimmune diseases.

    Michael Mahler;Marvin J. Fritzler

  • Autoantibodies to domain 1 of beta 2 glycoprotein 1: a promising candidate biomarker for risk management in antiphospholipid syndrome.

    Michael Mahler;Gary L. Norman;Pier Luigi Meroni;Munther Khamashta

  • Clinical and serologic correlates of anti-PM/Scl antibodies in systemic sclerosis: a multicenter study of 763 patients.

    Julie D'Aoust;Marie Hudson;Solène Tatibouet;James Wick

  • International multicenter evaluation of autoantibodies to ribosomal P proteins.

    Michael Mahler;Kai Kessenbrock;Magdalena Szmyrka;Yoshinari Takasaki

Frequent Co-Authors

Marvin J. Fritzler
Marvin J. Fritzler University of Calgary
Gary L. Norman
Gary L. Norman University of Debrecen
Pier Luigi Meroni
Pier Luigi Meroni Istituto Auxologico Italiano
Maria Orietta Borghi
Maria Orietta Borghi University of Milan
Gabriella Lakos
Gabriella Lakos Thermo Fisher Scientific (United States)
Minoru Satoh
Minoru Satoh RMIT University
Cem Gabay
Cem Gabay University of Geneva
Yehuda Shoenfeld
Yehuda Shoenfeld Sheba Medical Center
Angela Tincani
Angela Tincani University of Brescia

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For those interested in Immunology, exploring related healthcare degrees can broaden career options. Accelerated nursing programs offer an efficient route into the nursing field, especially for individuals switching careers or seeking faster entry. Programs labeled as accelerated nursing programs near me provide convenient opportunities for students to advance their education in a shorter time frame.

Non-nurses aiming to enter nursing can benefit from online nursing programs for non nurses. These flexible options accommodate busy schedules and allow students to build foundational skills essential for medical and immunological research or clinical practice.

Specializations like Family Nurse Practitioner are gaining popularity for those wanting to work closely with patients on immune-related health concerns. Those looking for quick advancement should explore accelerated fnp programs, which provide intensive training with an online format that supports working professionals.

For entry-level positions, lpn schools easy to get into offer straightforward paths to licensed practical nursing roles. These programs can serve as stepping stones toward more specialized immunology-related careers or advanced nursing studies.

Best Scientists Citing Michael Mahler

Trending Scientists

Recently Published Articles